Work

There Is No Unmet Need for Another Programmed Cell Death Protein-1 or Programmed Death-Ligand 1 Inhibitor for Metastatic NSCLC

Year: 2022

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2022.08.003

Authors: Ibiayi Dagogo-Jack, Zofia Piotrowska

Institutions: Harvard University, Massachusetts General Hospital

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Boehringer Ingelheim, American Lung Association, Pfizer, AstraZeneca, Bayer, Novartis, Spectrum Pharmaceuticals, Array BioPharma, Takeda Pharmaceuticals U.S.A., Jazz Pharmaceuticals, Genentech

OpenAlex ID: W4298393500

FWCI: 0.091

Cites: 15

Cited by: 1

Related to: 10